Results 101 to 110 of about 9,592 (219)

Biological Degradation of Phthalates: From Bioremediation to Plastic Waste Valorization

open access: yesChemSusChem, Volume 19, Issue 7, 14 April 2026.
Phthalic acid isomers play a key role in the plastics industry, but pose significant environmental and health concerns. This review explores the microbial biodegradation of phthalates and their esters, focusing on bacterial enzymes, catabolic pathways, and cellular uptake mechanisms of phthalates.
Marco A. Pereyra‐Camacho, Isabel Pardo
wiley   +1 more source

Drosophila melanogaster as a Model Host for the Burkholderia cepacia Complex

open access: yesPLoS ONE, 2010
Colonization with bacterial species from the Burkholderia cepacia complex (Bcc) is associated with fast health decline among individuals with cystic fibrosis. In order to investigate the virulence of the Bcc, several alternative infection models have been developed.
Castonguay-Vanier, Josée   +3 more
openaire   +5 more sources

A Simple and Label‐Free Gold Nanoparticle Assay and Duplex PCR for Rapid Detection of Klebsiella pneumoniae K2

open access: yesMicrobiologyOpen, Volume 15, Issue 2, April 2026.
A rapid, cost‐effective dual‐detection strategy for Klebsiella pneumoniae K2 was developed by combining a label‐free AuNP colorimetric assay (LOD: 1.56 ng/μL, 60 min) with duplex PCR targeting K2A and orf10 genes (LOD: 1 pg/μL). This approach enables rapid screening with accurate genetic validation for point‐of‐care diagnostics in resource‐limited ...
Sepideh Ahmadi   +2 more
wiley   +1 more source

Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

open access: yes, 2012
Chronic pulmonary infection is one of the hallmarks of lung disease in cystic fibrosis. Infections dominated by organisms of the Burkholderia cepacia complex, a group of at least 17 closely-related species of gram-negative bacteria, are particularly ...
Alex Horsley   +3 more
core   +1 more source

Burkholderia ambifaria sp nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.

open access: yes, 2001
A polyphasic taxonomic study, including amplified fragment length polymorphism (AFLP) fingerprinting, DNA-DNA hybridizations, DNA base-ratio determinations, phylogenetic analysis, whole-cell fatty acid analyses and an extensive biochemical ...
LiPuma, J. J.   +15 more
core   +1 more source

Isolation and Characterization of Burkholderia Cepacia Strains from Hospitalized Patients in the Hospitals of West Guilan Province

open access: yesMedical Laboratory Journal, 2014
Background and Objective: Burkholderia cepacia complex (BCC) is a plant pathogen that is an important mortality factor in immune-compromised and hospitalized patients.
M Elmi Merian, M Faezi Ghasemi
doaj  

LOWER RESPIRATORY TRACT MICROBIOTA AND ITS SENSITIVITY TO ANTIBACTERIAL AGENTS IN CHILDREN WITH CYSTIC FIBROSIS

open access: yesМать и дитя в Кузбассе, 2022
Cystic fibrosis is an autosomal recessive disease characterized by involvement of all exocrine glands, vital organs and systems. CFTR protein dysfunction leads to chronic infection and subsequent uncontrolled inflammation.
Яков Яковлевич Яковлев   +5 more
doaj  

Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides

open access: yesInnate Immunity, 2008
The Burkholderia cepacia complex comprises 10 closely related Gram-negative organisms all of which appear capable of causing disease in humans. These organisms appear of particular relevance to patients with cystic fibrosis. Lipopolysaccharide (LPS) is an important virulence determinant in Gram-negative pathogens. In this review, we highlight important
A. De Soyza   +4 more
openaire   +4 more sources

Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp nov

open access: yes, 2004
Phenotypic and genotypic studies revealed new tools for differentiating Burkholderia cepacia genomovar VI from Burkholderia multivorans and other B. cepacia-complex species. Hence, the name Burkholderia dolosa sp. nov. is proposed, with LMG 18943T (=CCUG
LiPuma, J. J.   +11 more
core   +1 more source

Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

open access: yes, 2020
BackgroundChronic pulmonary infection is a hallmark of lung disease in cystic fibrosis. Infections dominated by organisms of the Burkholderia cepacia complex, a group of at least 18 closely‐related species of gram‐negative bacteria, are particularly ...
Horsley, Alexander; id_orcid
core   +1 more source

Home - About - Disclaimer - Privacy